Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Assumption of a Supplement Based on the Extract From Camelia Leaf Sinensis on Basal Metabolism and Body Composition in Overweight Women or With Obesity in Postmenopause

NCT05031702 is registered in ClinicalTrials.gov with Azienda di Servizi alla Persona di Pavia as lead sponsor.

NCT NCT05031702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05031702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Assumption of a Supplement Based on the Extract From Camelia Leaf Sinensis on Basal Metabolism and Body Composition in Overweight Women or With Obesity in Postmenopause
Lead sponsor
Azienda di Servizi alla Persona di Pavia
Phase
Not applicable
Overall status
Unknown status
Start date
March 8, 2021
Completion date
July 25, 2022
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal disorder